Immunotherapy and Targeted Therapy in Patients With Advanced Melanoma and the V600 BRAF Mutation: Which One First? D. Moreno-Ramírez, A. Fernández-Orland, L. Ferrándiz

Hypereosinophilic Syndrome and T-Cell Lymphoma: Which Comes First? M. Meruelo Ruano, N. González Romero, A. Lobato Izagirre, I. Gainza Apraiz

Epidemiology of Melanoma in Spain: Estimation of Number of Patients With Stage III Disease Eligible for Adjuvant Therapies E. Nagore, D. Moreno-Ramírez, P. Ortiz-Romero, E. Martín-Sánchez, A. Martínez-Fernández, S. Puig